Overcoming the Obstacles
Mr. Shukla is of the opinion that the major challenges of the pharmaceutical industry is arranging the finance and working out shoe string budgets.
Zerico Lifesciences has crossed revenueof INR 14.35 Cr in the financial of 2018-19 and is growing at a considerable percentage Year on Year since its inception in 2013
The company has launched products which are used in the treatment of common diseases in India at very affordable prices. The USP is the freedom of operation, trust based approach and no paper work. The approach has helped the organisation to be perceived as humane. The company is positioned as employee friendly, customer oriented and result driven organisation. “Our products have found immediate acceptance by practicing doctors both in India and abroad. At present, 70 products are spread all over India and over more than 20 countries around the world. As one of the fast growing pharmaceutical companies in India, we are backed by a dedicated team of over 200 professionals, who are well trained in every aspect of pharmaceutical Industry”, states Mr. Shukla.
Growth and what lies ahead
Zerico has launched many unique products including an innovative product for the treatment of PCOS, a major lifestyle disease affecting women and got it manufactured from Akums Pharmaceuticals the largest manufacturer in the country ensuring unique and quality product catering to the need of the masses. The company generally gets its products manufactured from WHO GMP approved plants only. It has crossed revenue of INR 14.35 Cr in the financial of 2018-19 and is growing at a considerable percentage Year on Year since its inception in 2013. Expressing the good will and the future ahead for the company, Mr. Sachin Shukla concludes, “We work regularly in the field meeting our important customers. We meet and discuss different aspects of our strategies, success stories and the action plans. We have team with 15 to 20 years of Domain experience having excellent successful track record in their previous assignments which ensures expected results. We have plans to create more specialty divisions to strengthen our presence in other specialties. Also, we wish to expand the team size to 500 in next 3 years’ time.”